DTC Battle: PhRMA Should Pay More Attention To Issue, Sen. Craig Says
Executive Summary
The pharmaceutical industry will come under increased scrutiny for direct-to-consumer advertising of Rx drugs as a drug benefit is added to Medicare, Senate Special Committee on Aging Chairman Larry Craig (R-Idaho) suggested
You may also be interested in...
Vivus Muse Ad Omits Route Of Administration, FDA Warning Letter Says
A television advertisement for Vivus' erectile dysfunction urethral suppository Muse (alprostadil) fails to disclose the route of administration, an FDA warning letter says
Vivus Muse Ad Omits Route Of Administration, FDA Warning Letter Says
A television advertisement for Vivus' erectile dysfunction urethral suppository Muse (alprostadil) fails to disclose the route of administration, an FDA warning letter says
Fujisawa Prograf Risk Education Plan Requested By FDA Warning Letter
Fujisawa will implement a Prograf risk education plan for physicians in response to FDA complaints that a journal ad for the organ rejection agent failed to present adequate risk information